Eyes on the prize

Key message articulation for leading science business

Our latest set of investor messages for Oxford BioMedica focus on this leading gene therapy company's ocular portfolio as they look to progress their science towards the next stage in the development pipeline.

thinkerdoer have articulated how Oxford BioMedica see value in the future of the sector, see themselves continuing to be world leaders in their field, and see how to turn thier science into commercial reality.

Using powerful macro eye photography by Philip Gatward and reflecting the headline messages into them, we created billbord style communication pieces telling investors 'the way we see it'.

investor communication materials / marketing collateral / photography and illustration